CEP Magazine
Should Highly Regulated Public Companies Have Board-Level Compliance Committees?
November 2021
In this CEP Magazine article, Sidley partners Holly J. Gregory and Paul E. Kalb, MD, the co-chair of Sidley’s Executive Compensation and Corporate Governance practice and the global head of Sidley’s Healthcare and FDA Group, respectively, discuss the considerations evaluating whether highly regulated public companies should have board-level compliance committees.
Copyright 2021 CEP Magazine, a publication of the Society of Corporate Compliance and Ethics (SCCE).
Offices
Capabilities
Suggested News & Insights
Earnouts, AI, and Equitable Remedies: Delaware Court Reinstates CEO and Extends Payout ClockMarch 31, 2026Parties to Delaware LLC Agreements Cannot Circumvent Fiduciary Duty Waivers via Implied Covenant of Good Faith and Fair DealingMarch 27, 2026Private Equity Investment in U.S. Law Firms (Part II): Deal Architecture, Regulatory Boundaries, and the Lender PlaybookMarch 25, 2026Sidley Recognized in Legal 500 EMEA 2026March 25, 2026Fifth Circuit Holds U.S. FTC’s In-House Adjudication of Deceptive Advertising Claim Unconstitutional Under JarkesyMarch 24, 2026Activist That Encouraged Merger Only To Change Its Mind Denied “Extraordinary Remedy” Of A Deal InjunctionMarch 18, 2026
- Stay Up To DateSubscribe to Sidley Publications
- Follow Sidley on Social MediaSocial Media Directory